EUROPEAN JOURNAL OF NEUROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2023-07-03 ms46451948626387 来自江苏省

偏重的研究方向：运动障碍疾病
经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊

44 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2023-07-21 ms46451948626387 来自江苏省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：运动障碍疾病
经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……

40 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2023-05-08 ms1000000741572856 来自广东省

投稿命中率:25.0
偏重的研究方向：神经病学
经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？

50 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2022-05-13 147490c1m23暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：认知障碍
经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2022-05-15 147490c1m23暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）

76 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2022-01-18 Doc.hcy

各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？

122 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2023-05-08 ms1000000741572856 来自广东省

偏重的研究方向：神经病学
经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。

54 0

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2022-11-18 12092a3am81暂无昵称

审稿速度:2.0
偏重的研究方向：运动障碍疾病
经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~

84 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2022-06-30 程莫斯

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经病学
经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。

81 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146093, encodeId=c47f2146093b2, content=偏重的研究方向：运动障碍疾病 经验分享：4.23日投稿，到现在还在under review，发了催稿信也没有回应，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Mon Jul 03 13:59:51 CST 2023, time=2023-07-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149115, encodeId=a82921491154e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：运动障碍疾病 经验分享：4.23投稿后第二天under review，中间催稿一次，7.21拒稿，拒稿意见还算中肯……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/sYGhMtSDd4YYE7bC7eAgPA6UwjMvxBicY2fm5p3OPZVdNSYlXkwyj4yib5yhma4YmpqQEPNUgaI1pGj53IfvFzRw/132, createdBy=a0ec5143026, createdName=ms46451948626387, createdTime=Fri Jul 21 09:37:15 CST 2023, time=2023-07-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131001, encodeId=555621310017f, content=投稿命中率:25.0 偏重的研究方向：神经病学 经验分享：很奇怪，不知道为什么，投稿后两天才发一个提交成功的邮件，然后点进去系统呈现是d r a f t状态，这是提交成功了吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:46:05 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219364, encodeId=3dc6121936475, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：认知障碍 经验分享：投了40天了还没回应。under review其实还是在编辑手里没送审。上一次21天拒稿不给理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Fri May 13 15:14:25 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219754, encodeId=17271219e5410, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：根本不快。2020-4-05日投稿，5-15日还不确定送审了没有（在编辑手里和送审都是under review）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91b45204994, createdName=147490c1m23暂无昵称, createdTime=Sun May 15 12:12:32 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185395, encodeId=9dd911853953c, content=各位投过的说说这个审稿一般是多久啊，我投的under review已经45天了，这个常见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/06/6421324b19a31b330dbd47f531be661e.jpg, createdBy=73f72456587, createdName=Doc.hcy, createdTime=Tue Jan 18 00:14:28 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130999, encodeId=de1f21309993f, content=偏重的研究方向：神经病学 经验分享：很奇怪，为什么投稿成功后，稿件的状态是d r a f t，是提交成功了，还是没提交成功。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd35613068, createdName=ms1000000741572856, createdTime=Mon May 08 17:43:32 CST 2023, time=2023-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101374, encodeId=beb821013e4f2, content=审稿速度:2.0 偏重的研究方向：运动障碍疾病 经验分享：纯粹来记录下投稿细节：第一次投这个杂志，10.07submit，11.17晚上reject with resumit as a new manuscript，第一次接触这种大修方式，起初看还以为被拒稿了（不给修的那种），后面发现可能是投稿系统的风格，祈祷修回顺利！后续有进展，再来更新~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17292190746, createdName=12092a3am81暂无昵称, createdTime=Fri Nov 18 19:42:36 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229804, encodeId=06b41229804ca, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：再次感受到了杂志的高效率，🤗🤗🤗 2022-5-29 sumbit 2022-5-30 under review 2022-6-16 reject with invitation to resubmit 2022-6-29修改后重新 sumbit 2022-6-60 accept 总结起来就是快，期刊质量很不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YXkGow4MAcsFmz6stxqlxhRADap6P5HDcfmKBT5HozgkGHdlML0QkvFiaoIUiboyjOliaUUlOCSpSsvHqcUQVFYZw/132, createdBy=fa0f5285546, createdName=程莫斯, createdTime=Thu Jun 30 22:32:43 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208274, encodeId=abf912082e42c, content=审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Sat Apr 02 23:32:59 CST 2022, time=2022-04-02, status=1, ipAttribution=)]

2022-04-02 水木清华观自在

审稿速度很快，有些小毛病比如作者的单位序号也会帮忙修正，接收后1周online，ORCID同时更新，PUBMED也会查到。

93 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务